Wong Lab Publications
Learn more about research being performed in the Wong Lab by reading our latest publications.
Recent Publications
The integrated stress response promotes immune evasion through lipocalin 2
Nature. 2026 Feb 18;
Design and Development of DNA Damage Chemical Inducers of Proximity for Targeted Cancer Therapy
Journal of the American Chemical Society. 2026 Jan 14; 148:1153-1163
Phase 1b Study of Dazostinag Plus Pembrolizumab After Hypofractionated Radiotherapy in Patients With Select Advanced Solid Tumors
Cancer research communications. 2025 Dec 01; 5:2249-2263
TNG260 is a Small-Molecule CoREST Inhibitor that Sensitizes STK11-Mutant Tumors to Anti-PD-1 Immunotherapy
Cancer research. 2025 Oct 15; 85:3966-3982
Deep mutational scanning reveals EGFR mutations conferring resistance to the 4th-generation EGFR tyrosine kinase inhibitor BLU-945
NPJ precision oncology. 2025 Aug 20; 9:294
A Phase 1/2 multicenter trial of DKN-01 as monotherapy or in combination with docetaxel for the treatment of metastatic castration-resistant prostate cancer (mCRPC)
Prostate cancer & prostatic diseases. 2025 Jun ; 28:363-369
Surgical Resection of Murine PDAC Alters Hepatic Metastases and Immune Microenvironment
Pancreas. 2025 May 23;
In Vivo Efficacy of a Macrocyclic Peptoid-Peptide Hybrid That Selectively Modulates the Beta-Catenin/TCF Interaction to Inhibit Prostate Cancer
Prostate. 2025 May ; 85:646-658